Australia markets close in 5 hours 48 minutes

Zealand Pharma A/S (0NZU.IL)

IOB - IOB Delayed price. Currency in DKK
Add to watchlist
333.70+9.40 (+2.90%)
At close: 06:31PM GMT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
343,478
103,986
292,567
353,314
41,333
Cost of revenue
5,162
0
118,814
90,565
415
Gross profit
338,316
103,986
173,753
262,749
40,918
Operating expenses
Research development
656,199
614,044
588,453
604,081
561,423
Selling general and administrative
253,059
306,541
636,256
488,026
67,881
Total operating expenses
909,258
920,585
1,223,950
1,091,505
628,860
Operating income or loss
-570,942
-816,599
-1,050,197
-828,756
-587,942
Interest expense
43,764
56,455
4,091
2,895
3,205
Total other income/expenses net
-
-
30,777
-4,068
9,242
Income before tax
-765,981
-972,041
-1,026,940
-839,653
-576,677
Income tax expense
-5,931
-6,431
-8,791
7,076
-5,136
Income from continuing operations
-760,050
-965,610
-1,018,149
-846,729
-571,541
Net income
-781,437
-1,202,135
-1,018,149
-846,729
-571,541
Net income available to common shareholders
-781,437
-1,202,135
-1,018,149
-846,729
-571,541
Basic EPS
-19.11
-26.02
-23.75
-22.07
-16.91
Diluted EPS
-19.11
-26.02
-23.75
-22.07
-16.91
Basic average shares
51,751
46,200
42,869
38,370
33,802
Diluted average shares
51,751
46,200
42,869
38,370
33,802